Scarica l'app Stockscreener
6.18
0.82%
0.05
Dopo l'orario di chiusura:
6.18
Precedente Chiudi:
$6.13
Aprire:
$6.14
Volume 24 ore:
2.63M
Relative Volume:
0.72
Capitalizzazione di mercato:
$947.55M
Reddito:
$418.84M
Utile/perdita netta:
$-1.60M
Rapporto P/E:
-600.00
EPS:
-0.0103
Flusso di cassa netto:
$69.77M
1 W Prestazione:
-2.22%
1M Prestazione:
+12.36%
6M Prestazione:
-46.86%
1 anno Prestazione:
-53.50%
Intervallo 1D:
$6.125
$6.31
Intervallo di 1 settimana:
$5.81
$6.46
Portata 52W:
$5.19
$13.88
Certara Inc Stock (CERT) Company Profile
Nome
Certara Inc
Settore
Industria
Telefono
(415) 237-8272
Indirizzo
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
6.18 | 947.55M | 418.84M | -1.60M | 69.77M | -0.0103 |
VEEV
Veeva Systems Inc
|
171.60 | 28.03B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.58 | 10.16B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
55.00 | 9.87B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.40 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
24.98 | 4.61B | 637.78M | 239.40M | 307.21M | 1.1909 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Overweight → Equal Weight |
| 2026-02-27 | Downgrade | Craig Hallum | Buy → Hold |
| 2026-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-09-29 | Iniziato | Craig Hallum | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-09-27 | Aggiornamento | UBS | Neutral → Buy |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Perform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-10 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-04-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Iniziato | Berenberg | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-01 | Iniziato | Piper Sandler | Overweight |
| 2022-01-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-23 | Iniziato | Robert W. Baird | Outperform |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Iniziato | BofA Securities | Buy |
| 2021-01-05 | Iniziato | Credit Suisse | Neutral |
| 2021-01-05 | Iniziato | Jefferies | Hold |
| 2021-01-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Certara Inc Borsa (CERT) Ultime notizie
Certara (CERT) price target decreased by 23.74% to 9.63 - MSN
AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance Singapore
Certara strategic business divestiture comes at right time, says analyst - MSN
Certara | D: Filing D - Moomoo
Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates - MSN
Certara to sell regulatory and medical writing business for up to $135M - MSN
How The Certara (CERT) Story Is Shifting As Analysts Recut Targets And Expectations - Yahoo Finance
Wall Street analysts think Certara (CERT) could surge 43.28%: Read this before placing a bet - MSN
Certara: An Interesting Situation To Keep Track Off (NASDAQ:CERT) - Seeking Alpha
CERT Price Today: Certara, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
(CERT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Barclays Remains a Hold on Certara (CERT) - The Globe and Mail
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - MSN
CERT Certara posts 8.8 percent year-over-year Q4 2025 revenue growth despite sizeable EPS miss pressuring shares.Barrier to Entry - UBND thành phố Hải Phòng
Certara to Divest Regulatory and Medical Writing Business - The Globe and Mail
Certara to sell regulatory writing unit to Veristat for $135M By Investing.com - Investing.com India
Is Certara (CERT) stock considered stable (+2.26%) 2026-04-22Price Surge - Cổng thông tin điện tử tỉnh Lào Cai
Certara (CERT) Sells Regulatory Writing Business for Up to $135 Million - GuruFocus
Veristat to Acquire Certara’s Regulatory and Medical Writing Business - Business Wire
William Blair Maintains Certara(CERT.US) With Hold Rating - Moomoo
Veristat, LLC signed a definitive agreement to acquire Regulatory and Medical Writing business of Certara, Inc for approximately $140 million. - marketscreener.com
Craig-Hallum Initiates Certara(CERT.US) With Hold Rating - Moomoo
Certara Shares Rise Amid Plan to Sell Portion of Business to Veristat - Moomoo
Certara to Sell Regulatory and Medical Writing Business to Veristat for Up to $135 Million, Refocuses on Model-Informed Drug Development 1 - Minichart
Certara to sell regulatory writing unit to Veristat for $135M - Investing.com
Certara to Sell Regulatory, Medical Writing Business to Veristat for $135 Million - marketscreener.com
Certara : Regulatory and Medical Writing – Supplemental Information - marketscreener.com
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat - The Manila Times
Certara to Sell Global Medical Writing Business to Veristat for $100M, Plus Up to $35M Earn-Out - TradingView
Certara (NASDAQ: CERT) divests regulatory and medical writing unit to Veristat - Stock Titan
Analysts Conflicted on These Healthcare Names: Vivos Therapeutics (VVOS), Certara (CERT) and Option Care Health (OPCH) - The Globe and Mail
Certara, Inc. $CERT Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Why Certara (CERT) Stock Is Rising Now (Investor Interest) 2026-04-16Safe Entry Stocks - Xã Thanh Hà
Certara Inc Azioni (CERT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Certara Inc Azioni (CERT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McKemey Adrian | President, Drug Dev. Solutions |
Apr 01 '26 |
Option Exercise |
0.00 |
10,849 |
0 |
10,849 |
| Corcoran Daniel | SVP and General Counsel |
Apr 01 '26 |
Option Exercise |
0.00 |
10,849 |
0 |
27,070 |
| Gallagher John E | Chief Financial Officer |
Apr 01 '26 |
Option Exercise |
0.00 |
50,605 |
0 |
103,174 |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH |
Apr 01 '26 |
Option Exercise |
0.00 |
33,167 |
0 |
339,581 |
| Anhalt Rona | Chief Human Resources Officer |
Apr 01 '26 |
Option Exercise |
0.00 |
9,764 |
0 |
14,945 |
| Feehery William F | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.30 |
24,096 |
200,000 |
2,360,769 |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF |
Sep 09 '25 |
Sale |
10.92 |
51,224 |
559,366 |
73,979 |
1.72%
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):